Beneath is a roundup of present well being information briefs.
FDA approves Eli Lilly’s drug for uncommon blood most cancers
Eli Lilly and Co stated Friday that the US well being regulator has permitted its drug for the remedy of a uncommon type of blood most cancers. The wholesale price of the remedy, Jaypirca, can be $21,000 for 30 days for the 200mg dose, the US drugmaker instructed Reuters.
France extends obligatory COVID assessments for Chinese language vacationers till February 15
France has prolonged obligatory COVID assessments for vacationers from China till February 15, a authorities decree printed on Saturday confirmed. Whereas Chinese language officers have stated infections have peaked, some world consultants have warned of the opportunity of a surge in instances in rural areas much less geared up to take care of them, as thousands and thousands of Chinese language journey for household gatherings in the course of the holidays. Lunar New 12 months vacation.
Dozens of Yanomami youngsters hospitalized in northern Brazil amid well being disaster
Dozens of indigenous youngsters affected by malnutrition and acute sickness have been hospitalized in northern Brazil, with kin in hammocks supporting their emaciated frames in scenes that underscore the gravity of a public well being disaster. The well being secretary of Boa Vista, the capital of Roraima state, stated Friday that 59 indigenous youngsters are at present within the state’s solely pediatric hospital, 45 of them from the Yanomami individuals. Eight have been in intensive care.
J&J says blood most cancers drug improves progression-free survival in sufferers
Johnson & Johnson stated Friday that an interim evaluation confirmed that its drug Carvykti met the first purpose of bettering progression-free survival in sufferers with a kind of blood most cancers in a late-stage research. The corporate is testing Carvykti in sufferers with a number of myeloma, with a historical past of relapse, who’ve stopped responding to present remedy and have obtained one to 3 prior therapies.
US FDA proposes to ease sexual abstinence rule for blood donors
The US well being regulator on Friday proposed new blood donation pointers for males who’ve intercourse with males which can be primarily based on particular person threat moderately than blanket necessities, a transfer it stated is according to different nations and can assist to make sure that US blood provide. The US Meals and Drug Administration stated the principles are aimed toward lowering the chance of HIV transmission by transfusions and are much like these within the UK and Canada.
HCA Healthcare sees elective procedures choose up as staffing points ease
Administration at HCA Healthcare Inc on Friday forecast decrease labor prices and a restoration in non-urgent procedures by 2023 as staffing tendencies improved following an exodus of nurses in the course of the pandemic. The remark helped ship shares of the biggest for-profit hospital operator within the US reversing course and rising as a lot as 2%. Rivals Tenet Healthcare and Common Well being Providers additionally rose 2% and 1%.
Unique-EU could pay extra for Pfizer COVID injections in alternate for decrease quantity
Brussels is discussing with Pfizer and BioNTech the opportunity of lowering as much as 500 million doses of the COVID-19 vaccine that the EU has promised to purchase this yr in alternate for the next worth, stated a supply with information of the talks. An extension to the supply deadline, probably till the second half of 2024, can also be on the desk, the supply stated. They declined to be recognized as a result of the conversations are confidential.
Omicron’s XBB.1.5 subvariant accounts for 61.three% of US COVID instances – CDC
Omicron’s XBB.1.5 subvariant has possible turn into the dominant variant in the US, accounting for 61.three% of COVID instances within the week ending Jan. 28, knowledge from the Facilities for The US Illness Management and Prevention subvariate accounted for 49.5% of instances within the week ending Jan. 21, CDC estimates confirmed.
China approves two domestically developed COVID medication
China has permitted two domestically developed oral medication for COVID-19 sufferers with gentle signs, the Nationwide Medical Merchandise Administration stated on Sunday. The medication, used to deal with grownup sufferers with gentle to reasonable COVID-19 infections, have been developed by Simcere Pharmaceutical Group. <2096. HK> and a unit of Shanghai Junshi Biosciences Co Ltd, the administration stated in an announcement on its web site.
(With contributions from businesses).
